Literature DB >> 20675435

Bleomycin revisited: towards a more representative model of IPF?

Chris J Scotton, Rachel C Chambers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675435     DOI: 10.1152/ajplung.00258.2010

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


× No keyword cloud information.
  18 in total

Review 1.  Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.

Authors:  Marek Barczyk; Matthias Schmidt; Sabrina Mattoli
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

2.  Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis.

Authors:  Elizabeth F Redente; Kristen M Jacobsen; Joshua J Solomon; Abigail R Lara; Sarah Faubel; Rebecca C Keith; Peter M Henson; Gregory P Downey; David W H Riches
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-08       Impact factor: 5.464

Review 3.  Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement.

Authors:  Sebastian Altenhöfer; Kim A Radermacher; Pamela W M Kleikers; Kirstin Wingler; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2014-02-26       Impact factor: 8.401

4.  Radiation-induced impairment in lung lymphatic vasculature.

Authors:  Ye Cui; Julie Wilder; Cecilia Rietz; Andrew Gigliotti; Xiaomeng Tang; Yuanyuan Shi; Raymond Guilmette; Hao Wang; Gautam George; Eduarda Nilo de Magaldi; Sarah G Chu; Melanie Doyle-Eisele; Jacob D McDonald; Ivan O Rosas; Souheil El-Chemaly
Journal:  Lymphat Res Biol       Date:  2014-12       Impact factor: 2.589

5.  Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease.

Authors:  Rebecca Lee; Charles Reese; Michael Bonner; Elena Tourkina; Zoltan Hajdu; Ellen C Riemer; Richard M Silver; Richard P Visconti; Stanley Hoffman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-28       Impact factor: 5.464

6.  Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment.

Authors:  Laura E Stevens; Anna Arnal-Estapé; Don X Nguyen
Journal:  J Vis Exp       Date:  2018-06-28       Impact factor: 1.355

Review 7.  Novel therapeutic approaches for pulmonary fibrosis.

Authors:  Arnab Datta; Chris J Scotton; Rachel C Chambers
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

8.  Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice.

Authors:  Yan Cai; Mitsuhiro Yoneda; Takeshi Tomita; Reiko Kurotani; Minoru Okamoto; Taketomo Kido; Hiroyuki Abe; Wayne Mitzner; Arjun Guha; Shioko Kimura
Journal:  BMC Pulm Med       Date:  2015-07-16       Impact factor: 3.317

9.  The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.

Authors:  Natalia Smoktunowicz; Robert E Alexander; Linda Franklin; Andrew E Williams; Beverley Holman; Paul F Mercer; Gabor Jarai; Chris J Scotton; Rachel C Chambers
Journal:  Dis Model Mech       Date:  2015-07-02       Impact factor: 5.758

10.  Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences.

Authors:  Taisuke Akamatsu; Yosifumi Arai; Isao Kosugi; Hideya Kawasaki; Shiori Meguro; Makiko Sakao; Kiyoshi Shibata; Takafumi Suda; Kingo Chida; Toshihide Iwashita
Journal:  Fibrogenesis Tissue Repair       Date:  2013-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.